NEU 2.97% $18.62 neuren pharmaceuticals limited

Ann: Comment on research report, page-86

  1. 2,573 Posts.
    lightbulb Created with Sketch. 397
    This is when you’d like to see all other brokerage houses unleash their collective views on this report, which obviously goes against their views.

    Be great to see them all rebut this report - if they had balls and conviction they’d do so as I imagine they’d have many questions from their clients.

    Have Culper seen through their research?

    I wait with baited breath…
    Last edited by good1234: 16/02/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.